Home/Filings/4/0001193125-25-239077
4//SEC Filing

BURNETT JOSEPH 4

Accession 0001193125-25-239077

CIK 0001285550other

Filed

Oct 13, 8:00 PM ET

Accepted

Oct 14, 4:33 PM ET

Size

12.0 KB

Accession

0001193125-25-239077

Insider Transaction Report

Form 4
Period: 2025-10-10
BURNETT JOSEPH
DirectorCEO and President
Transactions
  • Sale

    Common Stock

    2025-10-10$28.64/sh1,981$56,736217,359 total(indirect: See Footnote)
  • Sale

    Common Stock

    2025-10-10$27.64/sh6,599$182,396219,340 total(indirect: See Footnote)
  • Sale

    Common Stock

    2025-10-10$26.51/sh17,583$466,125225,939 total(indirect: See Footnote)
  • Sale

    Common Stock

    2025-10-10$29.21/sh300$8,763217,059 total(indirect: See Footnote)
Holdings
  • Common Stock

    11,311
Footnotes (5)
  • [F1]The sale of shares reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 11, 2025 in accordance with Rule 10b5-1.
  • [F2]Represents a weighted average sales price per share. The shares were sold at prices ranging from $26.07 to $27.06. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F3]These shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Joseph M. Burnett as trustee of the trust.
  • [F4]Represents a weighted average sales price per share. The shares were sold at prices ranging from $27.08 to $28.07. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F5]Represents a weighted average sales price per share. The shares were sold at prices ranging from $28.08 to $29.05. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Documents

1 file

Issuer

ClearPoint Neuro, Inc.

CIK 0001285550

Entity typeother

Related Parties

1
  • filerCIK 0001721010

Filing Metadata

Form type
4
Filed
Oct 13, 8:00 PM ET
Accepted
Oct 14, 4:33 PM ET
Size
12.0 KB